PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism BRKR Q1 2026 Earnings EPS Surges Past Estimates by Over 30 TBCH Q1 2026 Earnings EPS Misses Estimates Sharply Yet Stock Surges Over 11 DRMA Q1 2026 Earnings NarrowerthanExpected Loss Marks Progress for ClinicalStage Biotech HOVR Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Focuses on Development VLYPP Q1 2026 Earnings Preferred EPS Beats Estimates Stock Declines Slightly